Dr. Kareen Coulombe joined us to share her latest findings for assessing cardiac toxicity using a predictive 3D human cardiac microtissue platform for assessing toxicity of chemical compounds. What you’ll… Read more »
Mamta Behl, M.S, Ph.D, D.A.B.T, explores the latest developments in neurotoxicity models. This method uses a combination of in vitro, in vivo extrapolation, and exposure assessment to rapidly screen compounds with… Read more »
Join us on Thursday, April 29th, at 11am for a webinar highlighting alternatives to in vivo animal testing that instead leverage PBPK modeling. This webinar will be presented by Dr. Scott Slattery, a cell biologist at ScitoVation.
Congratulations to Jake Reske! His abstract on transcriptomic predictive modeling for drug-induced cholestasis with ScitoVation was selected as a finalist for the Environmental Mutagenesis and Genomics Society Bioinformatics Challenge 2021.
Thanks to all who joined us on Tuesday, Mar. 30, for a special review of how PBPK modeling can be successfully applied to pesticide risk assessment, presented by Dr. Cecilia Tan, of the US EPA Office of Pesticide Programs. If you missed it, you may view the recording.
Visitors to the ScitoVation ToxExpo booth from March 15 to 25th will have a chance to win a Bose Home Speaker 500: Smart Bluetooth Speaker with Alexa Voice Control Built-in (Value… Read more »
ScitoVation will be exhibiting at ToxExpo™ during the SOT (Society of Toxicology) Annual Meeting. If you’ll be attending, please stop by our virtual booth, #1310, for a chance to win our drawing.
Our second webinar of 2021 was a huge success, we had more than 275 registrants! If you were unable to join us for this presentation, you are in luck: just click below to access a recording of the event!
PFAS PBPK Models: Current Status and Progress Needed To Predict Hypothalamic-Pituitary-Thyroid Axis Perturbations
Please join us on Monday, Feb. 8, for a special educational webinar presented by Dr. Jeffrey Fisher, Senior Science Fellow for the Computational Biology Division of ScitoVation.
One of the premier thought leaders in the area of physiologically based pharmacokinetic modeling (PBPK), Dr. Fisher’s research interests have focused on the development and application of pharmacokinetic and biologically based mathematical models to ascertain health risks from environmental, food-borne and occupational chemical exposures.